Cargando…

Ixekizumab for the Treatment of Acrodermatitis Continua of Hallopeau and Inverse Psoriasis

Detalles Bibliográficos
Autores principales: Xia, Rui Yuan, Liu, Jian, Chen, Dan Dan, Diao, Zi Yue, Gao, Ya Mei, Yin, Zhi Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238979/
https://www.ncbi.nlm.nih.gov/pubmed/37275799
http://dx.doi.org/10.4103/ijd.ijd_884_22
_version_ 1785053399420502016
author Xia, Rui Yuan
Liu, Jian
Chen, Dan Dan
Diao, Zi Yue
Gao, Ya Mei
Yin, Zhi Qiang
author_facet Xia, Rui Yuan
Liu, Jian
Chen, Dan Dan
Diao, Zi Yue
Gao, Ya Mei
Yin, Zhi Qiang
author_sort Xia, Rui Yuan
collection PubMed
description
format Online
Article
Text
id pubmed-10238979
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-102389792023-06-04 Ixekizumab for the Treatment of Acrodermatitis Continua of Hallopeau and Inverse Psoriasis Xia, Rui Yuan Liu, Jian Chen, Dan Dan Diao, Zi Yue Gao, Ya Mei Yin, Zhi Qiang Indian J Dermatol Correspondence Wolters Kluwer - Medknow 2023 /pmc/articles/PMC10238979/ /pubmed/37275799 http://dx.doi.org/10.4103/ijd.ijd_884_22 Text en Copyright: © 2023 Indian Journal of Dermatology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Correspondence
Xia, Rui Yuan
Liu, Jian
Chen, Dan Dan
Diao, Zi Yue
Gao, Ya Mei
Yin, Zhi Qiang
Ixekizumab for the Treatment of Acrodermatitis Continua of Hallopeau and Inverse Psoriasis
title Ixekizumab for the Treatment of Acrodermatitis Continua of Hallopeau and Inverse Psoriasis
title_full Ixekizumab for the Treatment of Acrodermatitis Continua of Hallopeau and Inverse Psoriasis
title_fullStr Ixekizumab for the Treatment of Acrodermatitis Continua of Hallopeau and Inverse Psoriasis
title_full_unstemmed Ixekizumab for the Treatment of Acrodermatitis Continua of Hallopeau and Inverse Psoriasis
title_short Ixekizumab for the Treatment of Acrodermatitis Continua of Hallopeau and Inverse Psoriasis
title_sort ixekizumab for the treatment of acrodermatitis continua of hallopeau and inverse psoriasis
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238979/
https://www.ncbi.nlm.nih.gov/pubmed/37275799
http://dx.doi.org/10.4103/ijd.ijd_884_22
work_keys_str_mv AT xiaruiyuan ixekizumabforthetreatmentofacrodermatitiscontinuaofhallopeauandinversepsoriasis
AT liujian ixekizumabforthetreatmentofacrodermatitiscontinuaofhallopeauandinversepsoriasis
AT chendandan ixekizumabforthetreatmentofacrodermatitiscontinuaofhallopeauandinversepsoriasis
AT diaoziyue ixekizumabforthetreatmentofacrodermatitiscontinuaofhallopeauandinversepsoriasis
AT gaoyamei ixekizumabforthetreatmentofacrodermatitiscontinuaofhallopeauandinversepsoriasis
AT yinzhiqiang ixekizumabforthetreatmentofacrodermatitiscontinuaofhallopeauandinversepsoriasis